Radient Technologies Inc. - President & CEO Denis Taschuk
President & CEO Denis Taschuk
Source: Radient Technologies
  • Radient Technologies (RTI) signs a strategic licensing agreement with HighGrade Supply Ltd.
  • The agreement grants Radient exclusive rights to the HighGrade technology, HighGrade IP, and established cannabis culture legacy brand
  • HighGrade will provide expertise, technical guidance, consultation, labour and knowledge for Radient to produce an array of pristine end products using multiple solvents
  • Radient will be adding a team of trained staff with proven expertise and a wealth of knowledge of cannabis inputs and high-quality end products
  • Radient Technologies (RTI) is up 5.26 per cent and is trading at C$0.10 at 11:09 am ET

Radient Technologies Inc. (RTI)  signs an exclusive licensing and extraction agreement with HighGrade Supply Ltd.

Radient will produce a wide range of premium concentrates for sale in both the medicinal and rapidly growing recreational cannabis markets in Canada.

The agreement grants Radient exclusive rights to the HighGrade technology, HighGrade IP, and established cannabis culture legacy brand.

The HighGrade team has been innovating and perfecting cannabis processing technology in Canada for the last decade.

The team has experimented with every viable extraction technology in the market and is set to release a wide range of top quality and affordable cannabis products across the country for the recreational, medical, and wholesale B2B markets.

Under the terms of the agreement, HighGrade will provide expertise, technical guidance, consultation, labour and knowledge for Radient to produce an array of pristine end products using multiple solvents with the focus but not limited to high output hydrocarbon products, minor cannabinoid isolates, and terpene distillates.

HighGrade is providing RTI with a custom hydrocarbon system designed for high throughput and purity.

The capacity of the HighGrade team will be 1,100 kgs of biomass daily between hydrocarbons and other solvents with room to grow as the demand in the Canadian market increases.

Radient will be adding a team of trained staff with proven expertise and a wealth of knowledge of cannabis inputs and high-quality end products.

The HighGrade team will bring its legacy brands into the Radient fold and will bring to market some of the highest quality cannabis 2.0 products, including:

Radient will in turn make use of its standard processing and sales licenses with its quality systems to rapidly launch products while meeting all of Health Canada’s requirements under the Cannabis Act and Cannabis Regulations.

The focus will be for Radient to provide a wide range of affordable but top-quality cannabis products to the recreational, medicinal, and wholesale B2B markets and is expected to be made available in July 2021.

Radient anticipates products to be launched as a part of this agreement starting calendar Q3 2021 following the recent completion of the provincial registration process in Alberta, Saskatchewan, British Columbia, Yukon, NWT, Nunavut, Manitoba, Ontario, and the Maritime provinces.

The sales offtake through all channels is expected to be approximately 200 kg of productper month starting July 2021, growing to over 4000 kg per annum from calendar Q1 2022 onwards.

Radient expects that demand for high-quality premium concentrates based on hydrocarbon extracts will form a core part of the recreational Cannabis 2.0 market in Canada.

This will be a highly transformative milestone for Radient as it continues to build its revenue profile and roll out innovative cannabinoid products and formulations.

Radient Technologies is an innovative science-based company that is a commercial manufacturer of high-quality cannabinoid-based formulations, ingredients and products.

Radient Technologies (RTI) is up 5.26 per cent and is trading at C$0.10 at 11:09 am ET.

More From The Market Online

Buzz on the Bullboards: Looking for volatility-proof stocks?

Investors saw developments in Canadian and U.S. stock markets, with attention on decisions made by central banks and moves in key sectors.
Scientific labratory

How a small-cap tech stock is broadening MRI technology 

Nanalysis Scientific (TSXV:NSCI) develops and makes compact MRI and nuclear magnetic resonance devices for clinical, lab and industrial use.

Canopy Growth fuels turnaround story with fresh capital

Canopy Growth (TSX:WEED) continues its turnaround story with a C$96.3 million exchange and subscription deal with an institutional investor.

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.